Related Experiment Video
Updated: Jun 4, 2026

Real-time Cytotoxicity Assays in Human Whole Blood
Published on: November 7, 2014
Impact of high-throughput screening in biomedical research
Ricardo Macarron1, Martyn N Banks, Dejan Bojanic
1Department of Sample Management Technologies, GlaxoSmithKline, Mail Stop UP 12-200, 1250S Collegeville Rd, Collegeville, Pennsylvania 19426, USA. ricardo.macarron@gsk.com
Abstract:
High-throughput screening (HTS) has been postulated in several quarters to be a contributory factor to the decline in productivity in the pharmaceutical industry. Moreover, it has been blamed for stifling the creativity that drug discovery demands. In this article, we aim to dispel these myths and present the case for the use of HTS as part of a proven scientific tool kit, the wider use of which is essential for the discovery of new chemotypes.

